Active Recombinant Human CD200R1 protein, His&hFc-tagged
|Product Overview :||Recombinant Human CD200R1 protein(AAI43394.1)(Met1-Leu266), fused with His&hFc tag, was expressed in HEK293.|
- Gene Information
- Related Products
|Form :||Lyophilized from sterile PBS, pH 7.4Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the hard copy of CoA.|
|Bio-activity :||Measured by its binding ability in a functional ELISA. Immobilized recombinant human CD200 at 1 μg/ml (100ul/well) can bind human CD200R1 / Fc Chimera with a linear range of 0.12-16 ng/ml.|
|Molecular Mass :||The secreted recombinant human CD200R1/Fc is a disulfide-linked homodimeric protein. The reduced monomer comprises 488 amino acids and has a predicted molecular mass of 54.9 kDa. As a result of glycosylation, rh CD200R1/Fc monomer migrates as an approximately 90-100 kDa band in SDS-PAGE under reducing conditions.|
|Protein Length :||Met1-Leu266|
|Endotoxin :||< 1.0 EU per μg of the protein as determined by the LAL method|
|Purity :||> 94 % as determined by SDS-PAGE|
|Storage :||Samples are stable for up to twelve months from date of receipt at -20°C to -80°C
Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|Reconstitution :||It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4°C before opening to recover the entire contents.|
|Gene Name :||CD200R1 CD200 receptor 1 [ Homo sapiens ]|
|Official Symbol :||CD200R1|
|Synonyms :||CD200R1; CD200 receptor 1; MOX2 receptor , MOX2R; cell surface glycoprotein CD200 receptor 1; CD200R; HCRTR2; OX2R; MOX2 receptor; CD200 cell surface glycoprotein receptor; cell surface glycoprotein OX2 receptor 1; cell surface glycoprotein receptor CD200; MOX2R;|
|Gene ID :||131450|
|mRNA Refseq :||NM_138806|
|Protein Refseq :||NP_620161|
|UniProt ID :||Q8TD46|
|◆ Recombinant Protein|
|Cd200r1-2054M||Recombinant Mouse Cd200r1 Protein, Myc/DDK-tagged||+Inquiry|
|CD200R1-172H||Recombinant Human CD200R1 Protein, His (Fc)-Avi-tagged||+Inquiry|
|Cd200r1-661M||Recombinant Mouse Cd200r1 Protein, His-tagged||+Inquiry|
|CD200R1-348H||Active Recombinant Human CD200R1 Protein, Fc-Avi-tagged, Biotinylated||+Inquiry|
|CD200R1-3057H||Recombinant Human CD200R1 Protein, MYC/DDK-tagged||+Inquiry|
|CD200R1-2483CCL||Recombinant Cynomolgus CD200R1 cell lysate||+Inquiry|
|CD200R1-2226MCL||Recombinant Mouse CD200R1 cell lysate||+Inquiry|
|CD200R1-2523HCL||Recombinant Human CD200R1 cell lysate||+Inquiry|
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Q&As (7)Ask a question
Modulating CD200R1 signaling holds therapeutic potential for immune-related disorders. Enhancing CD200R1 signaling or agonizing CD200R1 with specific agonists could help dampen excessive immune responses, attenuate inflammation, and promote immune tolerance. Conversely, inhibiting CD200R1 signaling or blocking CD200-CD200R1 interaction may be beneficial in conditions where immune suppression is desired, such as cancer immunotherapy. However, further research is needed to develop safe and effective therapeutic strategies targeting CD200R1, taking into consideration the potential impact on immune cell functions and overall immune homeostasis.
Dysregulation of CD200R1 signaling has been implicated in the pathogenesis of several diseases. Reduced CD200R1 expression or impaired CD200-CD200R1 interaction has been observed in autoimmune disorders, such as multiple sclerosis and rheumatoid arthritis. This dysregulation can lead to excessive activation of immune cells and chronic inflammation. Furthermore, altered CD200R1 expression has been reported in neuroinflammatory conditions, such as Alzheimer's disease and Parkinson's disease. However, more studies are required to elucidate the specific roles of CD200R1 dysregulation in disease development and progression.
CD200R1 (CD200 receptor 1) is primarily expressed on the surface of various immune cells, including macrophages, dendritic cells, and mast cells. It is also found on some non-immune cells, such as neurons. The specific cellular localization of CD200R1 allows it to interact with its ligand, CD200, which is expressed on many cell types, including neurons, endothelial cells, and immune cells. This interaction plays a crucial role in regulating immune responses and maintaining immune homeostasis.
CD200R1 plays a critical role in immune regulation and tolerance. The interaction between CD200R1 on immune cells and its ligand CD200 on target cells provides a potent inhibitory signal, suppressing immune cell activation and effector functions. This regulation helps prevent autoimmune responses and excessive inflammation. CD200R1 signaling inhibits the activation of immune cells, such as macrophages and dendritic cells, thereby reducing their pro-inflammatory cytokine production and antigen presentation capacity. Dysregulation of CD200R1 signaling has been associated with autoimmune diseases and neuroinflammatory disorders.
CD200R1 expression is regulated by various factors, including cytokines and transcriptional regulators. Pro-inflammatory cytokines, such as interferon-gamma, can downregulate CD200R1 expression on immune cells, whereas anti-inflammatory cytokines, such as interleukin-4, can upregulate its expression. Transcription factors, such as PU.1 and GATA-1, are involved in regulating CD200R1 gene expression. Additionally, epigenetic modifications, such as DNA methylation and histone acetylation, can influence CD200R1 expression levels. Further research is needed to fully understand the complex regulatory mechanisms governing CD200R1 expression.
CD200R1 engagement with its ligand CD200 triggers inhibitory signaling pathways, primarily mediated by immunoreceptor tyrosine-based inhibitory motifs (ITIMs) present in the CD200R1 cytoplasmic domain. Upon ligand binding, CD200R1 recruits and activates phosphatases, such as SHP-1 and SHP-2, which dephosphorylate downstream signaling molecules. This leads to the inhibition of various immune cell functions, including phagocytosis, cytokine production, and antigen presentation. The CD200R1-CD200 signaling axis is crucial for maintaining immune tolerance and preventing excessive immune activation.
Upon binding of CD200 to CD200R1, several downstream signaling pathways are activated. One of the main pathways involves the recruitment and activation of Src homology 2 domain-containing protein tyrosine phosphatase (SHP)-1 and SHP-2. These phosphatases inhibit signaling cascades initiated by immune receptors, including inhibitory signaling through the inhibitory receptor CD200R1 itself. Additionally, CD200R1 engagement can also lead to the modulation of PI3K-Akt and MAPK pathways, further influencing immune cell function and cytokine production.
Customer Reviews (3)Write a review
The convenience it offers saves a considerable amount of time and effort. -
The robustness of this reagent guarantees consistent results, regardless of the number of experiment replications. -
Purity personified, unlocking the gates to triumphant experiments. -
Ask a Question for All CD200R1 Products
Required fields are marked with *
My Review for All CD200R1 Products
Required fields are marked with *